Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07814365) titled 'PBI for Low-risk Breast Cancer' on Sept. 4.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Fudan University

Condition: Early-Stage Breast Cancer

Intervention: Radiation: 3-week PBI

Recruitment Status: Recruiting

Phase: N/A

Date of First Enrollment: September 16, 2021

Target Sample Size: 818

Countries of Recruitment: China

To know more, visit https://clinicaltrials.gov/study/NCT07814365

Published by HT Digital Content Services with permission from Health Daily Digest....